National Cancer Institute Division of Cancer Control

1
National Cancer InstituteDivision of
Cancer Control Population Sciences

• SBIR/STTR eHEALTH FUNDING OPPORTUNITIES for
• Small Grant Investigators

2
PROGRAM OBJECTIVES

• - Translate basic cancer science and research
  into prevention and control applications for
  medical and community settings.
• - Use innovative approaches and media technology
  to develop research-based programs,
  interventions, systems, networks, or products
  needed by the public or primary care
  professionals to reduce cancer risk or improve
  the quality of life of cancer survivors.

3
HOW DO WE DO THIS?
Two grant mechanisms are used to
translate science into commercial
applications SBIR R43/R44 Small
Business Innovation Research Grants
STTR R41/42 Small Business Technology
Transfer Grants -
for non-profits organizations
collaborating with small
businesses
4
HOW DO THESE TWO GRANTS DIFFER?
SBIR R43/R44 Small Business STTR
R41/42 Non-Profit Research
Control Research Control Phase I 6-12
months Same Direct Costs 100,000
Same Phase II 2-3 years Same
Direct Costs 750,000 Same Employed by
company 51 On non-profit staff
must work with small business
Must be U.S. citizen Same Due April 1,
August 1, December 1 Same
5
TRADITIONAL OR FAST TRACK
Traditional Fast Track Phase I
submitted, reviewed Phase I II submitted
reviewed at the if funded, completed in same
time if funded, given one score for 6-12
months both phases Phase I is 6-12
months Reviewers have option to separate and
fund Phase I only Phase II submitted,
completed Duration of Phase II - same In 2-4
years Funding gap between Funding gap 2-3
weeks Phase I II - 18 months Who applies?
Generally, mid-size small businesses with years
of experience in research or technology
development and grant writing
6
WHAT NEEDS TO BE ACCOMPLISHED? gt Phase
I feasibility test or pilot study gt Phase II
develops, implements, and tests the
effectiveness of new or existing models of
behavior modification or informational/
educational or training applications
7
New Requirements for eHealth SBIR/STTR
Applicants

• To improve the potential for successful
  commercialization, all Phase II applicants must
  address
• - organizational infrastructure issues
  Applicants must work with a site administrator
  to remove barriers to use
• - long-term tracking - Applicants must build-in a
  tracking component to evaluate sales and product
  usage
• - usability - Applicants must participant in
  usability testing at NCIs Technology Lab in
  addition to their independent usability testing.

8

• How are eHealth SBIR/STTR
• Research Categories Selected?
• Categories result from
• S Congressional Priorities for NCI
• S Senate Committees Report on NCI
• S NCI Directors Budget Proposal for Cancer
  Research
• S Expressed opinions of the NCAB
• S Expressed needs of primary care providers,
  oncologists and the public

9
EHEALTH RESEARCH CATEGORIES

• Life Styles Associated with Cancer Risk
  (nutrition intakes/ habits, smoking habits,
  physical activity, sun screening habits)
• Cancer Genetics (decisions-making)
• Communication Techniques (for specific cancers,
  hard to
• reach populations, physically
  challenged populations)
• - Innovative Alternative Teaching Training
  Methods
• Complementary Medicine Approaches
• Survivorship and Quality of Life Issues (pain
  management)
• Systems for Primary Care Professionals/Oncologists
  
• Systems for the Public (training, education,
  screening,
• assessment, treatment)
• - Clinical Trials

10

• APPLICANT CHARACTERISTICS
• - Research Oriented
• - Former University Faculty
• - Health Communication Experts
• - Media Technology Experts
• - MD, PhD, MPH, MA, MBA, JD

11
WHO ARE THE EHEALTH REVIEWERS?

• Deans of Public Health, Nursing, Medicine
• Professors of nursing medicine, oncology
  behavior and preventive medicine kinesiology
  music therapy and other CAM topics health
  communication community health psychology
  business health sciences and bio-communication
  pediatrics and human development surveys/data
  collection/statistics education
• Researches in social work, oncology, epidemiology
  clinical applications
• Media Technology companies

12
WHAT DO REVIEWERS EXPECT?

• Significance to science field and NCI activities
• Approach theory and experience-based
• Innovation use of technology/approach to
• problem
• Measurable outcomes
• Qualified investigators and research team
• Appropriate environment and equipment
• Safeguards for human subjects
• Realistic budget
• Commercialization Potential

13
REVIEW AND POTENTIAL FOR FUNDING

• SBIR/STTR External Reviewers monitored by
  a Scientific Review Administrator, NIH
• Center for Scientific Review
• Funding approximately 1/3 are funded
• Potential

14
FUNDING AN NIH SET-A-SIDE of
Institute Budgets Set-aside for SBIR RD FY 1997
and Beyond 2.5 must be spent Pay
lines - determined by the Budget Office -
based on the number of applications submitted
and funded from previous year, special
initiatives, and number of SBIR contracts -
FY04 SBIR pay line 200 STTR pay line 179
15
Linking Science with Business NCI SBIR/STTR
Product Showcases

Demonstrations Showcase I 10/2-3, 2000
22 products Showcase II 9/6-7, 2001 13
products Showcase III 9/25-26, 2003 19
products Video casts MTHC Linking
Science and Business Series can be seen at
http//videocast.nih.gov (click past events
under) Product information and grant
synthesis is continuously being posted on
Program homepage
16
EVERY THING YOU NEED TO KNOW ABOUT
SBIR/STTR GRANTS CONTRACTS
Your NIH SBIR/STTR RESOURCE
http//www.nih.gov/grants/funding/sbir.htm
17
What does your eHealth SBIR/STTR Program
Director do for you?

• Applicants and grantees may
• Contact staff ANYTIME, preferably by email
• Receive pre-application advice and guidance
• Receive post-review advice and guidance
• Receive post-award advice and guidance

18
For further information

• Connie Dresser, RDPH, LN
• Acting NCI SBIR Liaison to the NIH OD
• Program Director, Multimedia Technology
• Health Communication SBIR Grants
• Health Communication Informatics Research
  Branch
• Behavioral Research Program
• Division of Cancer Control Population
  Sciences
• National Cancer Institute
• 6130 Executive Blvd, EPN - Rm. 4072
• Bethesda, MD 20892-7365
• 301/435-2846
• 301/480-2087 Fax
• cd34b_at_nih.gov
• http//cancercontrol.cancer.gov/hcirb/sbir/

19
(No Transcript)
20
(No Transcript)